LATEST ALERTS
US tobacco giant Altria is to pay $235m to settle at least 6,000 state and federal cases related to Juul, ending most of the suits it is still facing in relation to the e-cigarette company
Altria has swapped its 35% stake in Juul Labs for heated tobacco intellectual property rights, ending an investment which plummeted in value from $12.8bn to only $250m in just over four years
The investment value of Altria in e-cig company Juul fell by 65% in almost a year due to the recent developments in the US affecting the brand
Altria’s global net revenues rose 0.3% year-on-year in the third quarter of 2019 to $6.86bn, primarily due to higher net revenues in the smokeless products segment
TobaccoIntelligence considers the effects the possible re-merger of Philip Morris International (PMI) and Altria might have on the combustible and alternatives markets in the US and beyond
This report provides an overview of the South Korean heated tobacco market in terms of consumption, market size, brands and prices
Despite negative publicity on a national TV show and static numbers of vapers, the market for e-cigarettes continues to grow in China as consumer preferences change
US tobacco company Altria has revised its expectations for the US cigarette industry downwards, with a predicted decline up to 6% through 2023
The South Korean government is running a campaign to discourage use of tobacco products, in response to recent launches of Juul and a similar device from KT&G
The Delhi High Court has granted interim relief to e-cigarette vendors in India, delaying until 17th May the effects of a government circular calling for a nationwide ban on vaping products
The two leading brands in the vaping and heated tobacco sectors, Juul and Philip Morris International (PMI), are both engaged in active fights with Chinese companies over their intellectual property rights
Israel’s prime minister Benjamin Netanyahu has signed an administrative order prohibiting the import and marketing of any e-cigarette product with a nicotine concentration higher than 20 mg/ml
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
